RxDoctor Payments Data

Ioannis Avramis, MD

Orthopaedic Surgery · Plano, TXNPI 1457513012

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (49.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Acuity Surgical Devices, LLC at 52.2% of the total. 2025 is the largest year on record at $56,397, 2.9 times the $19,704 reported in 2019. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$118,164in general payments, 2019–2025

Across 173 payments — averaging $683.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acuity Surgical Devices, LLC$62K
  • Medical Device Business Services, Inc.$43K
  • Lifenet Health$7K
  • Johnson & Johnson$4K
  • Depuy Synthes Products, Inc.$1K
  • Brainlab, Inc.$305
  • plus $764 from 8 others
$21,423in research payments, 2019–2025

Across 6 payments — averaging $3570.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$20K
  • Pacira Pharmaceuticals Incorporated$2K

What the payments were for

  • Royalty or licence$58,21849%
  • Consulting fees$46,47339%
  • Travel & lodging$4,3274%
  • Food & beverage$8,4557%
  • Entertainment$6921%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$118,164 in reported general payments places this provider in the 90th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024
$426,220
Medicare patients
258
Services billed
1,289

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen57$1,449
Methocarbamol56$1,114
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen26$683

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Plano

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →